Epidemiology and prevention of breast cancer

Annual Review of Public Health

Volumn 17, Issue , 1996, Pages 47-67

  Kelsey, Jennifer L ^b   Bernstein, Leslie ^b  

^a STANFORD UNIVERSITY   (United States)

^b NONE

Author keywords

breast cancer; epidemiology; prevention

Indexed keywords

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CONFERENCE PAPER; FEMALE; HUMAN; OBESITY; PRIORITY JOURNAL;

EID: 0029866312     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pu.17.050196.000403     Document Type: Conference Paper

References (65)

1. Aldercreutz H, Mousavi Y, Clark J, Hockerstedt K, Hamalainen E, et al. 1992. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Mol. Biol. 41:331-37
2. Ambrosone CB, Freudenheim JL, Marshall JR, Graham S, Vena JE, et al. 1995. N-acetyltransferase (NAT), cigarette smoking, and breast cancer risk. Proc. Am. Assoc. Cancer Res. 36:283 (Abstr.)
3. Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK. 1994. Physical exercise and reduced risk of breast cancer in young women. J. Natl. Cancer Inst. 86:1403-8
4. Bernstein L, Ross RK. 1993. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15:48-65
5. Bernstein L, Ross RK, Henderson BE. 1992. Prospects for the primary prevention of breast cancer. Am. J. Epidemiol. 135:142-52
6. Bernstein L, Ross RK, Lobo R, Hanisch R, Krailo MD, Henderson BE. 1987. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br. J. Cancer 55: 681-85
7. Bodian CA. 1993. Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol. Rev. 15:177-87
8. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, et al. 1995. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J. Nat Cancer Inst. 87:670-75
9. Brinton LA, Schairer C. 1993. Estrogen replacement therapy and breast cancer risk. Epidemiol. Rev. 15:66-79
10. Bush TL, Helzlsouer KJ. 1993. Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. Epidemiol. Rev. 15: 233-43
11. Claus EB, Risch NJ, Thompson WD. 1990. Age at onset as an indicator of familial risk of breast cancer. Am. J. Epidemiol. 131:961-72
12. Daling JR, Malone KE, Voigt LF, White E, Weiss N. 1994. Risk of breast cancer among young women: relationship to induced abortion. J. Natl. Cancer Inst. 86:1584-92
13. Dao TL. 1981. The role of ovarian steroid hormones in mammary carcinogenesis. In Hormones and Breast Cancer (Bradbury Rep. no. 8), ed. MC Pike, PK Siiteri, CW Welsch, pp. 281-95. Cold Spring Harbor, NY: Cold Spring Harbor Lab.
14. Davis DL, Bradlow HL. 1995. Can environmental estrogens cause breast cancer? Sci. Am. 273:166-72
15. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. 1993. The life-time risk of developing breast cancer. J. Natl. Cancer Inst. 85:892-97
16. Friedenreich CM, Rohan TE. 1995. A review of physical activity and breast cancer. Epidemiology 6:311-17
17. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, et al. 1994. BRCA1 mutations in primary breast cancer and ovarian carcinomas. Science 266:120-22
18. Gammon MD, John EM. 1993. Recent etiologic hypotheses concerning breast cancer. Epidemiol. Rev. 15:163-68
19. Garland FC, Garland CF, Gorham ED, Young JF. 1990. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev. Med. 19:614-22
20. Harris R, Leininger L. 1995. Clinical strategies for breast cancer screening: weighing and using the evidence. Ann. Intern. Med 122:539-47
21. Hoegh H, McKendry CJ, Wright WE, Young JL Jr. 1992. Cancer Incidence by Race/Ethnicity California, 1988-1989. Calif. DHS, Sacramento
22. Horn-Ross PL. 1993. Multiple primary cancers involving the breast. Epidemiol. Rev. 15:169-76
23. Howe G, Rohan T, Decarli A, Iscovich J, Kaldor J, et al. 1991. The association between alcohol and breast cancer risk: evidence from the combined analysis of six dietary case-control studies. Int. J. Cancer 47:707-10
24. Hulka BS, Stark AT. 1995. Breast cancer: cause and prevention. Lancet 346: 883-87
25. Hunter DJ, Willett WC. 1993. Diet, body size, and breast cancer. Epidemiol. Rev. 15:110-32
26. Institute of Medicine, Committee to Review the Women's Health Initiative. 1993. An Assessment of the NIH Women's Health Initiative. Washington, DC: Natl. Acad.
27. John EM, Kelsey JL. 1993. Radiation and other environmental exposures and breast cancer. Epidemiol. Rev. 15:157-62
28. Jordan VC. 1990. Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifen. J. Natl. Cancer Inst. 82:1662-63
29. Kelsey JL, Gammon MD, John EM. 1993. Reproductive factors and breast cancer. Epidemiol. Rev. 15:36-47
30. Kelsey JL, Horn-Ross PL. 1993. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol. Rev. 15:7-16
31. Kelsey JL, Whittemore AS. 1994. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview. Ann. Epidemiol. 4:89-95
32. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. 1993. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270:2444-50
33. King MC, Rowell S, Love SM. 1993. Inherited breast and ovarian cancer. JAMA 269:1975-80
34. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. 1994. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J. Natl. Cancer Inst. 86:589-99
35. Longnecker MP. 1994. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 5:73-82
36. Love RR. 1993. The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. Cancer Epidemiol. Biomarkers Prev. 2:403-7
37. Malone KE. 1993. Diethylstilbestrol (DES) and breast cancer. Epidemiol. Rev. 15:108-9
38. Malone KE, Daling JR, Weiss NS. 1993. Oral contraceptives and breast cancer. Epidemiol. Rev. 15:80-97
39. McPherson K, Steel CM, Dixon JM. 1994. Breast cancer - epidemiology, risk factors, and genetics. Br. Med J. 309:1003-6
40. Messina M, Messina V, 1991. Increasing use of soyfoods and their potential role in cancer prevention. J. Am. Diet. Assoc. 91:836-40
41. Mittendorf R, Longnecker MP, Newcomb PA, Dietz AT, Greenbert ER, et al. 1995. Strenuous physical activity in young adulthood and risk of breast cancer. Cancer Causes Control. In press
42. Morrison AS. 1993. Screening for cancer of the breasi. Epidemiol. Rev. 15: 244-55
43. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg R, et al. 1994. Lactation and a reduced risk of premenopausal breast cancer. N. Engl. J. Med. 330:81-87
44. Oza AM, Boyd NF. 1993. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol. Rev. 15:196-208
45. Palmer JR, Rosenberg L. 1993. Cigarette smoking and the risk of breast cancer. Epidemiol. Rev. 15:145-56
46. Petrakis NL. 1993. Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol. Rev. 15:188-95
47. Pike MC, Spicer DV, Dahmoush L. Press MF. 1993. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15:17-35
48. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. 1983. "Hormonal" risk factors, "breast tissue age" and the age incidence of breast cancer. Nature 303:767-70
49. Pike MC, Ross RK, Lobo RA, Key TJ A, Potts M, Henderson BE. 1989. LHRH agonists and the prevention of breast and ovarian cancer. Br. J. Cancer 60: 142-48
50. Pollak M, Constantino J, Polychronakos C, Blauer SA, Guyda H, et al. 1990. Effects of tamoxifen on serum insulin-like growth factor 1 levels in stage I breast cancer patients. J. Natl. Cancer Inst. 82:1693-97
51. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. 1990. Increased cell division as a cause of human cancer. Cancer Res. 50:7415-21
52. Rosenberg L. 1994. Induced abortion and breast cancer: more scientific data are needed. (Editorial) J Natl. Cancer Inst. 86:1569-70
53. Schatzkin A, Longnecker MP. 1994. Alcohol and breast cancer: Where are we now and where do we go from here? Cancer 74:1101-10
54. Spicer DV, Pike MC, Pike A, Rude R, Shoupe D, Richardson J. 1993. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception 47:427-44
55. Spicer DV, Ursin G, Parinsky YR, Pearce JG, Shoupe D, et al. 1994. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J. Natl. Cancer Inst. 86:431-36
56. Stanford JL, Thomas DB. 1993. Exogenous progestins and breast cancer. Epidemiol Rev. 15:98-107
57. Stevens RG. 1987. Electric power use and breast cancer: a hypothesis. Am. J. Epidemiol. 125:556-61
58. Trichopoulos D. 1990. Hypothesis: Does breast cancer originate in utero? Lancet 335:939-40
59. Ursin G, Longnecker MP, Haile RW, Greenland S. 1995. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6: 137-41
60. Whelan EA, Sandler DP, Root J, Smith KR, Weinberg CR 1994. Menstrual cycle patterns and risk of breast cancer. Am. J. Epidemiol. 140:1081-90
61. Wingo PA, Tong T, Bolden S. 1995. Cancer Statistics, 1995. CA Cancer J. Clin. 45:8-30
62. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. 1993. Blood levels of organochlorine residues and risk of breast cancer. J. Natl. Cancer Inst. 85: 648-52
63. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, et al. 1994. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-90
64. Wrensch MR, Petrakis NL, Gruenke LD, Miike R, Ernster VL, et al. 1989. Breast fluid cholesterol and cholesterol β-epoxide concentrations in women with benign breast disease. Cancer Res. 49:2168-74
65. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, et al. 1993. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst. 85:1819-27